AGO2 anticorps
(1 reference)-
- Antigène Voir toutes AGO2 Anticorps
- AGO2 (Argonaute 2 (AGO2))
-
Reactivité
- Humain, Souris, Rat
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp AGO2 est non-conjugé
-
Application
- Immunohistochemistry (IHC)
- Attributs du produit
- Polyclonal Antibody
- Purification
- Affinity purification
- Immunogène
- A synthetic peptide of human Argonaute-2 (NP_036286.2).
- Isotype
- IgG
- Top Product
- Discover our top product AGO2 Anticorps primaire
-
anti-Argonaute 2 (AGO2) (AA 1-377) antibody
AGO2 Reactivité: Humain WB, ELISA, IF, IHC (p), RNAi Hôte: Souris Monoclonal 2E12-1C9 unconjugated
anti-Argonaute 2 (AGO2) (AA 517-818) antibodyAGO2 Reactivité: Humain WB, ELISA, IHC, ChIP Hôte: Lapin Polyclonal unconjugated
anti-Argonaute 2 (AGO2) (AA 1-100) antibodyAGO2 Reactivité: Humain WB, IHC Hôte: Lapin Polyclonal unconjugated
anti-Argonaute 2 (AGO2) (AA 27-59), (N-Term) antibodyAGO2 Reactivité: Humain WB, FACS, IHC (p) Hôte: Lapin Polyclonal RB8013 unconjugated
anti-Argonaute 2 (AGO2) (N-Term) antibodyAGO2 Reactivité: Humain, Souris, Rat WB, IHC Hôte: Lapin Polyclonal unconjugated
anti-Argonaute 2 (AGO2) (AA 47-115) antibodyAGO2 Reactivité: Humain WB, IF Hôte: Lapin Polyclonal unconjugated
anti-Argonaute 2 (AGO2) (AA 1-377) antibodyAGO2 Reactivité: Humain WB, ELISA Hôte: Souris Polyclonal unconjugated
anti-Argonaute 2 (AGO2) (AA 381-480) antibodyAGO2 Reactivité: Humain WB, ELISA Hôte: Souris Monoclonal 2H2 unconjugated
-
- Indications d'application
- IHC 1:50-1:200
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 1 mg/mL
- Buffer
- PBS with 0.02 % sodium azide, 50 % glycerol, pH 7.3
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- -20 °C
- Stockage commentaire
- Store at -20°C. Avoid freeze / thaw cycles.
-
-
: "Targeting a novel circITCH/miR-421/BTG1 axis is effective to suppress the malignant phenotypes in hepatocellular carcinoma (HCC) cells." dans: Cytotechnology, Vol. 75, Issue 3, pp. 255-267, (2023) (PubMed).
-
: "Targeting a novel circITCH/miR-421/BTG1 axis is effective to suppress the malignant phenotypes in hepatocellular carcinoma (HCC) cells." dans: Cytotechnology, Vol. 75, Issue 3, pp. 255-267, (2023) (PubMed).
-
- Antigène
- AGO2 (Argonaute 2 (AGO2))
- Autre désignation
- Argonaute-2 (AGO2 Produits)
- Sujet
- This gene encodes a member of the Argonaute family of proteins which play a role in RNA interference. The encoded protein is highly basic, and contains a PAZ domain and a PIWI domain. It may interact with dicer1 and play a role in short-interfering-RNA-mediated gene silencing. Multiple transcript variants encoding different isoforms have been found for this gene.
- ID gène
- 27161
- UniProt
- Q9UKV8
- Pathways
- Fc-epsilon Receptor Signaling Pathway, Regulatory RNA Pathways, EGFR Signaling Pathway, Neurotrophin Signaling Pathway, Ribonucleoprotein Complex Subunit Organization
-
